| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |